We empower executives, investors, and clinicians to be confident in their wound care business decisions.
Schedule a consultation or send us a message to tell us your unique situation.
Schedule a consultation or send us a message to tell us your unique situation.
Schedule a consultation or send us a message to tell us your unique situation.
How do we move forward?
The advanced wound care (AWC) sector has exploding growth, but can be dangerous to navigate if you don’t know what to look out for.
Our years of decision making and management experience, from the patient treatment room to the boardroom, helps you assess the wound care and tissue viability landscape to make decisions with confidence.
Where do we go next?
It’s easy to get burned by the unique conditions and considerations in each segment, care setting, and geography.
Our expertise in wound care business development consulting across the global medical and healthcare markets helps you seize new growth opportunities, while avoiding investment and partnership nightmares, sales and marketing headaches, payer and business model threats, and so much more.
Is this the right investment for me?
When it comes to wound care, accurate knowledge and the correct perspective is the difference between major profits and painful losses.
Diligence’s thorough research and deep insights from across the wound care spectrum help you to avoid uncertainty, make informed decisions, and give you peace of mind–whether you choose to make the move, or to walk away.
Are we maximizing our potential?
In the highly competitive world of advanced wound care, forward thinking is critical. Diligence stays on top of the latest developments, trends, technologies, and corporate activity in the field.
When you work with us, you can be confident that your decisions are informed, allowing you to maximize the value you deliver to your stakeholders.
How can we capitalize on opportunities in wound care services?
Driven by growth in chronic disease prevalence and an aging population, advanced wound care is a massive, booming, underserved healthcare opportunity.
Have you explored investment in advanced wound care services? Diligence has opened, managed, grown, and advised wound care centers and hospital units across the United States and four continents. Advanced Wound Care Global develops and manages AWC Centers of Excellence in markets with the greatest need and opportunity. We also help to drive the cutting edge of value based care, digital wound care services, and related innovative models.
Division VP
Advanced Wound Care
Medline
GM, Greater China and Southeast Asia
Acelity (KCI)
(acquired by 3M Company)
Global Director of Digital Health
Advanced Wound Care
ConvaTec
Be confident in your next move. This free guide will cover the following key dimensions for target due diligence, including:
He has opened and led award-winning, multi-million dollar wound care centers for the world’s largest wound care management and tissue viability provider. In this role, he directed clinicians and administrators, evaluated, purchased, and used advanced wound care products and services, and had full P&L responsibility of each center. Consistently exceeding clinical, operational, and financial goals, he and his team were named both a national Center of Excellence and mentor site, sharing best practices with other wound care programs.
Currently, Rafael personally heads all Diligence Wound Care Global consulting engagements to ensure that executives and investors we work with get the most powerful wound care intelligence and insights, while leveraging our global network of experts. An industry authority, he also serves on the boards of innovative companies, speaks at key industry events such as The European Wound Management Association (EWMA) conference and The Symposium on Advanced Wound Care (SAWC) among others, and is on the editorial advisory board of Today’s Wound Clinic.
Rafael received his MBA from The Coller School of Management, with studies at Nanyang Business School, and his BSc from The Robert H. Smith School of Business. He is a certified field medic, Six Sigma Red Belt, and speaks four languages. With a background spanning management consulting, VC, healthcare strategy, business development, and operations, Rafael has empowered and executed for wound care investors, startups, device, pharma, and services firms from New York City to Ho Chi Minh City.
Advanced wound dressings (AWD), allografts, amniotics, antimicrobials, autografts, bioactive glass, biologics, cellular and tissue products (CTPs), cleansers, compression therapy (active and passive), debridement (autolytic, biosurgical, enzymatic, mechanical, sharp surgical, ultrasonic), dermal regenerative tissue (DRT), diagnostics (Dx), digital and mobile health IT, durable medical equipment (DME), energy, light, plasma, and shockwave therapy, hemostatics, imaging, infection prevention and management, negative pressure wound therapy (NPWT), nutrition, offloading over-the-counter (OTC), oxygenators and hyperbaric oxygen therapy (HBOT), pain relief, pharmaceuticals, platelet-rich plasma (PRP, pressure offloading, regenerative medicine, remote patient monitoring (RPM), scar management, sensors and wearables, surgical closure, vascular interventions, and xenografts.
– Acute: Inpatient, surgical, burn center, long term acute care (LTAC), and hospital at home.
– Post-acute: Wound care center / clinic / ambulatory, skilled nursing facility (SNF), home health care.
– Digital health: Telemed / virtual / mHealth, electronic and virtual clinical trials, data analytics, predictive analytics, machine learning (ML), artificial intelligence (AI), clinical decision support (CDS), electronic medical records (EMRs), imaging, sensors, wearables, remote patient monitoring (RPM), connected devices, and smart tech.
– Wound types (etiologies): Arterial (ischemic), autoimmune and inflammatory-related, burns, diabetic foot ulcers (DFUs), infections, lymphedema, malignant (cancer) ulcers, neuropathic, osteomyelitis (bone infection) pressure injuries (PIs) / pressure ulcers (PUs), radiation injury (osteoradionecrosis / soft tissue radionecrosis / radiation dermatitis), skin tears, surgical complications / surgical site infections (SSIs), traumatic wounds, venous insufficiency / venous leg ulcers (VLUs), venous stasis dermatitis, other acute and non-healing / chronic wounds / ulcers and related skin and tissue viability conditions.
The customer and end-user perspective
Product strategy, commercialization, and business development
Service line planning, implementation, management, and clinical operations
The global medical and healthcare markets (developed, emerging, frontier)
At Diligence, the biggest thing we provide isn’t our wound care consulting services.